Xperix Inc. (KOSDAQ:317770)
South Korea · Delayed Price · Currency is KRW
3,035.00
-155.00 (-4.86%)
At close: Apr 2, 2026
Xperix Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Apr '26 Apr 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 112,743 | 93,004 | 68,161 | 135,095 | 45,199 | 51,766 |
| 22.84% | 36.45% | -49.55% | 198.89% | -12.68% | 9.44% |
| 130,309 | 94,292 | 70,225 | 98,213 | 14,710 | 19,935 |
| 3090.00 | 2795.00 | 2870.00 | 5930.00 | 2114.29 | 2421.43 |
| - | - | - | - | 14.93 | 16.06 |
| 5.25 | 4.33 | 4.62 | 11.34 | 3.00 | 3.57 |
| 1.23 | 1.01 | 1.16 | 2.40 | 0.94 | 1.15 |
| 1.46 | 1.20 | 1.23 | 2.48 | 0.98 | 1.19 |
| - | - | - | - | 18.08 | 28.44 |
| - | - | - | - | 15.64 | 26.39 |
| 6.06 | 4.39 | 4.76 | 8.25 | 0.98 | 1.37 |
| - | - | - | - | 4.40 | 5.72 |
| - | - | - | - | 5.22 | 6.64 |
| -37.63 | - | - | - | 5.88 | 10.95 |
| 0.13 | 0.13 | 0.40 | 0.02 | 0.01 | 0.01 |
| - | - | - | - | 0.10 | 0.11 |
| - | - | - | - | 0.14 | 0.22 |
| 0.08 | 0.08 | 0.07 | -0.38 | -0.64 | -0.77 |
| -4.50 | -4.50 | -1.11 | 6.39 | -9.24 | -9.95 |
| -2.11 | -2.11 | -1.15 | 23.32 | -12.35 | -19.07 |
| 0.20 | 0.20 | 0.19 | 0.22 | 0.31 | 0.32 |
| 3.40 | 3.40 | 2.72 | 1.45 | 1.31 | 2.03 |
| 0.34 | 0.34 | 0.57 | 10.93 | 15.29 | 15.57 |
| 0.75 | 0.75 | 0.93 | 12.61 | 18.46 | 17.66 |
| -27.21% | -27.21% | -5.85% | -7.12% | 6.66% | 7.53% |
| -1.42% | -1.42% | -3.78% | -4.74% | 3.60% | 4.12% |
Return on Invested Capital (ROIC) | -2.68% | -3.07% | -9.73% | -16.14% | 20.59% | 32.76% |
Return on Capital Employed (ROCE) | -2.50% | -2.50% | -8.00% | -7.20% | 5.90% | 6.60% |
| -17.31% | -20.99% | -4.43% | -2.70% | 6.70% | 6.23% |
| -3.07% | -3.72% | -5.42% | -0.69% | 5.53% | 3.52% |
| -31.12% | -31.12% | -5.86% | -1.84% | -0.27% | -0.49% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.